Publications by authors named "David Wanner"

Claim this Profile
W
What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern.
Philipp Gauckler, Erica L Bettac, Manfred Nairz, Christina Duftner, Anna K Luger, David Wanner

Ann Rheum Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloak and dagger - secondary hemophygocytic lymphohistiocytosis caused by intravenous autoinfection.
Andreas Pircher, Stefan Koeck, Johannes Schatzlmayr, Armin Finkenstedt, Manfred Nairz, David Wanner

Am J Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose vemurafenib in hairy cell leukemia patients with active infection.
Jan-Paul Bohn, Andreas Pircher, David Wanner, David Vill, Bernhard Foeger

Am J Hematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib.
David Wanner, Jan-Paul Bohn, Jakob Rudzki, Günther Stockhammer, Michael Steurer

Ann Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia at ASH 2017.
David Wanner, Michael Steurer

Memo· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib for relapsed refractory hairy cell leukemia variant.
Jan-Paul Bohn, David Wanner, Michael Steurer

Leuk Lymphoma· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis